Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease

Author(s):  Corsini Lindsay, Williams LaVonn A

Issue:  Mar/Apr 2011 - Volume 15, Number 2
View All Articles in Issue

Page(s):  124-128

Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease Page 1
Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease Page 2
Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease Page 3
Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease Page 4
Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease Page 5

Download in electronic PDF format for $65

Abstract:  In the pediatric patient, histamine2-receptor antagonists and/or proton pump inhibitors are recommended for effective therapy of gastroesophageal reflux disease. Proton pump inhibitors, a group of drugs whose main action is a pronounced and long-lasting reduction of gastric acid production, are more cost effective than histamine2-receptor antagonists because of long-term and enhanced treatment outcome. The compounding of proton pump inhibitors is an exacting procedure. Compounding pharmacists have the potential to provide optimal pharmacologic treatment of gastroesophageal reflux disease to a young population that requires special attention.

Related Keywords: Lindsay Corsini, PharmD, LaVonn A. Williams, gastroesophageal reflux disease, GERD, children, infants, proton pump inhibitors, formulations, lansoprazole, omeprazole, pantoprazole, oral liquid suspensions

Related Categories: FORMULATIONS, GASTROENTEROLOGY, PEDIATRICS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease
Corsini Lindsay
, Williams LaVonn A
Mar/Apr 2011
Pg. 124-128

Compatibility of Flavoring Agents in Compounding Extemporaneous Omeprazole Oral Liquid
Chuong Monica
, Taglieri Catherine A, Huang Szu Yu, Sariol Anthony, Kitigawa Reina, Barman Koushik, Mistry Amee, Harris Donna L, Kerr Stephen G
Nov/Dec 2019
Pg. 504-510

Omeprazole 1 mg/mL and 4 mg/mL in Humco Flavor Sweet Sugar-Free Oral Liquid
Allen Loyd V Jr
Jan/Feb 2019
Pg. 58

Lansoprazole 3-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2010
Pg. 246

Pantoprazole Sodium 2-mg/mL Oral Liquid
Allen Loyd V Jr
Sep/Oct 2006
Pg. 391

The Effect of Manufacturer on the Compounding of Omeprazole Suspensions and Their Stability Assessment
Meissner Svenja
, Bansal Mahima, Dela Cruz Paula Donamae, Hanning Sara, Svirskis Darren
Mar/Apr 2020
Pg. 140-147

To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid
Chuong Monica C
, Taglieri Catherine A, Kerr Stephen G
Nov/Dec 2017
Pg. 500-512

Omeprazole 2-mg/mL Oral Liquid
Allen Loyd V Jr
Sep/Oct 2006
Pg. 389

Basics of Compounding for Raynaud's Disease
Glasnapp Andrew
Jul/Aug 2003
Pg. 288-291

Pediatric Compounding: Coloring Outside the Lines
Preckshot John
Jan/Feb 2001
Pg. 6-8

Particle Measuring Systems - USP <797> Environmental Monitoring Solutions